Bhalla, S.; Passarelli, R.; Biswas, A.; De, S.; Ghodoussipour, S.
Plasma-Derived Cell-Free DNA as a Biomarker for Early Detection, Prognostication, and Personalized Treatment of Urothelial Carcinoma. J. Clin. Med. 2024, 13, 2057.
https://doi.org/10.3390/jcm13072057
AMA Style
Bhalla S, Passarelli R, Biswas A, De S, Ghodoussipour S.
Plasma-Derived Cell-Free DNA as a Biomarker for Early Detection, Prognostication, and Personalized Treatment of Urothelial Carcinoma. Journal of Clinical Medicine. 2024; 13(7):2057.
https://doi.org/10.3390/jcm13072057
Chicago/Turabian Style
Bhalla, Sophia, Rachel Passarelli, Antara Biswas, Subhajyoti De, and Saum Ghodoussipour.
2024. "Plasma-Derived Cell-Free DNA as a Biomarker for Early Detection, Prognostication, and Personalized Treatment of Urothelial Carcinoma" Journal of Clinical Medicine 13, no. 7: 2057.
https://doi.org/10.3390/jcm13072057
APA Style
Bhalla, S., Passarelli, R., Biswas, A., De, S., & Ghodoussipour, S.
(2024). Plasma-Derived Cell-Free DNA as a Biomarker for Early Detection, Prognostication, and Personalized Treatment of Urothelial Carcinoma. Journal of Clinical Medicine, 13(7), 2057.
https://doi.org/10.3390/jcm13072057